MP:0000219 | increased neutrophil count | "greater than normal neutrophil numbers" [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Nlrp1aNeut1/Nlrp1aNeut1,Pycardtm1Vmd/Pycardtm1Vmd Genetic Background: involves: 129S1/Sv * 129X1/SvJ * C57BL/6
|
MP:0001845 | abnormal inflammatory response | "aberrant reaction of the microcirculation characterized by movement of fluid and leukocytes from the blood into extravascular tissues" [Pathology:ISBN 0-397-51047-0] |
Show
Allelic Composition: Il1atm1Yiw/Il1atm1Yiw,Nlrp1aNeut1/Nlrp1aNeut1 Genetic Background: involves: 129S1/Sv * 129X1/SvJ * C57BL/6
|
MP:0001876 | decreased inflammatory response | "less than expected response to injury, infection, or insult" [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Atf1tm1Gsc/Atf1tm1Gsc,Creb1tm2Gsc/Creb1+ Genetic Background: involves: 129/Sv * 129P2/SvPas * C57BL/6
|
MP:0002169 | no phenotype detected | "normal, viable and fertile appearance and behavior; indistinguishable from controls" [csmith:Cynthia L. Smith , Mouse Genome Informatics Curator] |
Show
Allelic Composition: Nlrp3tm1Hhf/Nlrp3+,Rag1tm1Mom/Rag1tm1Mom,Lyz2tm1(cre)Ifo/Lyz2+ Genetic Background: involves: 129/Sv * 129P2/OlaHsd * C57BL/6
|
MP:0002412 | increased susceptibility to bacterial infection | "greater likelihood that an organism will develop ill effects from a bacterial infection or from components of or toxins produced by bacteria" [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Nlrp3tm1Flv/Nlrp3tm1Flv,Slc11a1s/Slc11a1s Genetic Background: B6.129S5-Nlrp3tm1Flv
|
MP:0002418 | increased susceptibility to viral infection | "greater likelihood that an organism will develop ill effects from a viral infection or from components of or toxins produced by a virus" [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Nlrp3tm1Flv/Nlrp3tm1Flv Genetic Background: involves: 129S5/SvEvBrd * C57BL/6
|
MP:0002451 | abnormal macrophage physiology | "abnormal function or response of the phagocytic leukocytes involved in innate immunity, early non-adaptive phases of host-defense, antigen presentation, and which act as effector cells in humoral and cell-mediated immunity" [Immunobiology , The Immune System in Health and Disease:ISBN 0-8153-1691-7, cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Nlrp3tm1Flv/Nlrp3tm1Flv Genetic Background: involves: 129S5/SvEvBrd * C57BL/6
Allelic Composition: Pycardtm1Vmd/Pycardtm1Vmd Genetic Background: B6.129-Pycardtm1Vmd
|
MP:0002495 | increased IgA | "greater than normal immunoglobulin class A level" [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Atad1tm1.1Vdaw/Atad1tm1.1Vdaw Genetic Background: involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6
|
MP:0004502 | decreased incidence of chemically-induced tumors | "lower than normal frequency of tumor incidence induced by one or more chemical carcinogens or mutagens" [MGI:smb "Susan M. Bello, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Ptentm2.1Ppp/Ptentm2.1Ppp,Tg(Osr1-cre)4Mrt/0 Genetic Background: involves: 129S1/Sv * 129X1/SvJ
|
MP:0004842 | abnormal large intestine crypts of Lieberkuhn morphology | "any structural anomaly in the tubular intestinal glands found in the mucosal membranes of the large intestine" [ISBN:0-683-40008-8 "Stedman s Medical Dictionary, 27th edition"] |
Show
Allelic Composition: Atad1tm1.1Vdaw/Atad1tm1.1Vdaw Genetic Background: involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6
|
MP:0005025 | response to infection | "the body s reaction to invasion and multiplication of microorganisms in its tissues, or the body s reaction to components of or toxins produced by pathogenic mircroorganisms " [MeSH:National Library of Medicine - Medical Subject Headings , 2003, cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Mdm2tm1Glo/Mdm2+,Mdm4Gt(VICTR20)7Lex/Mdm4+,Trp53tm1Wahl/Trp53tm1Wahl Genetic Background: involves: 129S5/SvEvBrd * 129S7/SvEvBrd * C57BL/6
|
MP:0005616 | decreased susceptibility to type IV hypersensitivity reaction | "less likelihood of or resistance to developing an antigen-elicited cellular immune reaction that results in tissue damage, but does not require Ab participation; the response is seen at the area of contact" [Pathology:ISBN 0-397-51047-0, cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Nlrp3tm1Flv/Nlrp3tm1Flv Genetic Background: involves: 129S5/SvEvBrd * C57BL/6
|
MP:0008045 | decreased NK cell number | "reduction in the number of non-T, non-B lymphocytes, having a granular morphology and which are important in innate immunity to viruses and other intracellular pathogens; in addition, these cells can kill certain tumor cells" [ISBN:0-8153-1691-7 "Immunobiology, The Immune System in Health and Disease"] |
Show
Allelic Composition: Nlrp3tm1Flv/Nlrp3tm1Flv Genetic Background: involves: 129S5/SvEvBrd * C57BL/6
|
MP:0008136 | enlarged Peyer s patches | "increased size of the protruding lymphoid tissue located on the mucosa of the small intestine that is composed of densly packed B cell follicles" [PMID:15841100] |
Show
Allelic Composition: Atad1tm1.1Vdaw/Atad1tm1.1Vdaw Genetic Background: involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6
|
MP:0008537 | increased susceptibility to induced colitis | "increased severity or induction threshold of colitis upon treatment of an organism with intestinal inflammation agents such as dextran sodium sulfate (DSS)" [MGI:csmith "Cynthia L. Smith, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Atad1tm1.1Vdaw/Atad1tm1.1Vdaw Genetic Background: involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6
|
MP:0008560 | increased tumor necrosis factor secretion | "increase in the production or release of a serum glycoprotein produced by activated macrophages and NK cells and involved in initiating local inflammatory responses, particularly by its action on the endothelium of local blood vessels; its actions result in increased vascular permeability and induction of expression of adhesion molecules on the endothelium" [ISBN:0-8153-1691-7 "Immunobiology, The Immune System in Health and Disease", MESH:D12.644.276.374.500.800] |
Show
Allelic Composition: Pycardtm1Vmd/Pycardtm1Vmd Genetic Background: B6.129-Pycardtm1Vmd
|
MP:0008561 | decreased tumor necrosis factor secretion | "reduction in the production or release of a serum glycoprotein produced by activated macrophages and NK cells and involved in initiating local inflammatory responses, particularly by its action on the endothelium of local blood vessels; its actions result in increased vascular permeability and induction of expression of adhesion molecules on the endothelium" [ISBN:0-8153-1691-7 "Immunobiology, The Immune System in Health and Disease", MESH:D12.644.276.374.500.800] |
Show
Allelic Composition: Ptentm2.1Ppp/Ptentm2.1Ppp,Tg(Osr1-cre)4Mrt/0 Genetic Background: involves: 129S1/Sv * 129X1/SvJ
|
MP:0008564 | increased interferon-beta secretion | "increase in the production or release of one of the type I interferons produced by fibroblasts in response to stimulation by live or inactivated virus or by double-stranded RNA with antiviral, antiproliferative, and immunomodulating activity" [MESH:D12.644.276.374.440.890.275] |
Show
Allelic Composition: Pycardtm1Vmd/Pycardtm1Vmd Genetic Background: B6.129-Pycardtm1Vmd
|
MP:0008567 | decreased interferon-gamma secretion | "reduction in the production or release of the major interferon produced by mitogenically or antigenically stimulated lymphocytes that is involved in immunoregulation" [MESH:D12.644.276.374.440.893] |
Show
Allelic Composition: Lhx8tm1Awan/Lhx8tm1Awan Genetic Background: involves: 129S2/SvPas * C57BL/6J
|
MP:0008636 | decreased circulating interleukin-18 level | "reduction in the amount in the blood of a cytokine which enhances the cytotoxic activity of NK cells and cytotoxic T-cells and appears to play a role both as neuroimmunomodulator and in the induction of mucosal immunity" [MESH:D12.644.276.374.465.518] |
Show
Allelic Composition: Nlrp3tm1Flv/Nlrp3tm1Flv Genetic Background: involves: 129S5/SvEvBrd * C57BL/6
Allelic Composition: Pycardtm1Vmd/Pycardtm1Vmd Genetic Background: B6.129-Pycardtm1Vmd
|
MP:0008642 | decreased circulating interleukin-1 beta level | "reduction in the amount in the blood of an interleukin-1 subtype that is synthesized as an inactive membrane-bound pro-protein on monocytes, macrophages and other cells; proteolytic processing of the precursor form by caspase 1 results in release of the active form of interleukin-1beta from the membrane" [MESH:D12.644.276.374.465.501.600] |
Show
Allelic Composition: Nlrp3tm1Flv/Nlrp3tm1Flv Genetic Background: involves: 129S5/SvEvBrd * C57BL/6
Allelic Composition: Pycardtm1Vmd/Pycardtm1Vmd Genetic Background: B6.129-Pycardtm1Vmd
|
MP:0008655 | decreased interleukin-1 alpha secretion | "reduction in the production or release of an interleukin-1 subtype that occurs as a membrane-bound pro-protein form that is cleaved by proteases to form a secreted mature form; both membrane-bound and secreted forms of interleukin-1alpha are biologically active" [MESH:D12.644.276.374.465.501.300] |
Show
Allelic Composition: Atf1tm1Gsc/Atf1tm1Gsc,Creb1tm2Gsc/Creb1+ Genetic Background: involves: 129/Sv * 129P2/SvPas * C57BL/6
Allelic Composition: Pycardtm1Flv/Pycardtm1Flv Genetic Background: involves: 129S5/SvEvBrd * C57BL/6
Allelic Composition: Pycardtm1Ayaz/Pycardtm1Ayaz,Lyz2tm1(cre)Ifo/Lyz2+ Genetic Background: involves: 129P2/OlaHsd * C57BL/6J
|
MP:0008658 | decreased interleukin-1 beta secretion | "reduction in the production or release of an interleukin-1 subtype that is synthesized as an inactive membrane-bound pro-protein on monocytes, macrophages and other cells; proteolytic processing of the precursor form by caspase 1 results in release of the active form of interleukin-1beta from the membrane" [MESH:D12.644.276.374.465.501.600] |
Show
Allelic Composition: Atf1tm1Gsc/Atf1tm1Gsc,Creb1tm2Gsc/Creb1+ Genetic Background: involves: 129/Sv * 129P2/SvPas * C57BL/6
Allelic Composition: Pycardtm1Tno/Pycardtm1Tno Genetic Background: involves: 129S4/SvJae * C57BL/6
Allelic Composition: Pycardtm1Vmd/Pycardtm1Vmd Genetic Background: involves: 129S1/Sv * 129X1/SvJ
Allelic Composition: Pycardtm1Flv/Pycardtm1Flv Genetic Background: involves: 129S5/SvEvBrd * C57BL/6
Allelic Composition: Pycardtm1Nnz/Pycardtm1Nnz Genetic Background: involves: 129 * C57BL/6
Allelic Composition: Mefvtm5.1(MEFV)Chae/Mefvtm5.1(MEFV)Chae,Pycardtm1Tno/Pycardtm1Tno Genetic Background: involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6
Allelic Composition: Pycardtm1Vmd/Pycardtm1Vmd Genetic Background: B6.129-Pycardtm1Vmd
Allelic Composition: Pycardtm1Ayaz/Pycardtm1Ayaz,Lyz2tm1(cre)Ifo/Lyz2+ Genetic Background: involves: 129P2/OlaHsd * C57BL/6J
|
MP:0008685 | decreased interleukin-18 secretion | "reduction in the production or release of a cytokine which enhances the cytotoxic activity of NK cells and cytotoxic T-cells and appears to play a role both as neuroimmunomodulator and in the induction of mucosal immunity" [MESH:D12.644.276.374.465.518] |
Show
Allelic Composition: Atf1tm1Gsc/Atf1tm1Gsc,Creb1tm2Gsc/Creb1+ Genetic Background: involves: 129/Sv * 129P2/SvPas * C57BL/6
Allelic Composition: Pycardtm1Tno/Pycardtm1Tno Genetic Background: involves: 129S4/SvJae * C57BL/6
Allelic Composition: Pycardtm1Vmd/Pycardtm1Vmd Genetic Background: involves: 129S1/Sv * 129X1/SvJ
Allelic Composition: Pycardtm1Nnz/Pycardtm1Nnz Genetic Background: involves: 129 * C57BL/6
|
MP:0008706 | decreased interleukin-6 secretion | "reduction in the production or release of a cytokine that stimulates the growth and differentiation of B-cells and is also a growth factor for hybridomas and plasmacytomas, and is produced by many different cells including T-cells, monocytes and fibroblasts" [MESH:D12.644.276.374.465.506] |
Show
Allelic Composition: Pycardtm1Ayaz/Pycardtm1Ayaz,Lyz2tm1(cre)Ifo/Lyz2+ Genetic Background: involves: 129P2/OlaHsd * C57BL/6J
|
MP:0008734 | decreased susceptibility to endotoxin shock | "less than the expected early reaction of the microcirculation to endotoxins such as LPS, characterized by movement of fluid and leukocytes from the blood into extravascular tissues and often resulting in death" [MGI:tmeehan "Terry Meehan, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Pycardtm1Tno/Pycardtm1Tno Genetic Background: involves: 129S4/SvJae * C57BL/6
Allelic Composition: Pycardtm1Flv/Pycardtm1Flv Genetic Background: involves: 129S5/SvEvBrd * C57BL/6
Allelic Composition: Pycardtm1Vmd/Pycardtm1Vmd Genetic Background: B6.129-Pycardtm1Vmd
|
MP:0008896 | increased IgG2c level | "greater than normal immunoglobulin class G2c level" [MGI:csmith "Cynthia L. Smith, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Atad1tm1.1Vdaw/Atad1tm1.1Vdaw Genetic Background: involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6
|
MP:0010377 | abnormal gut flora balance | "anomaly in the ratio of microorganisms that live in the digestive tracts of animals, many of which perform symbiotic functions to the host" [MGI:csmith "Cynthia L. Smith, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Atad1tm1.1Vdaw/Atad1tm1.1Vdaw Genetic Background: involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6
|